History | Perioperative care in adults | Guidance | NICE

Guidance
Skip Standards and indicators submenu
Quality standards
Our quality standards set out priority areas for quality improvement. They highlight areas with identified variation in current practice.
View our quality standards
How to use our quality standards
The timeline for developing quality standards
Help us develop quality standards
Selecting and prioritising quality standards topics
About quality standards
Indicators
Our indicators measure outcomes that reflect the quality of care, or processes linked by evidence to improved outcomes.
View list of indicators
Learn about the committee that develops indicators
About indicators
Skip Life sciences submenu
Life Sciences
We offer tailored support to industry during product development. Our expertise can help you build the evidence needed to achieve market access.
View life sciences
Get support from NICE
NICE Advice service
Trusted, unrivalled expertise.
Make an enquiry
Contact us to discuss your requirements.
Innovative Licensing and Access Pathway (ILAP)
Streamlining patient access to safe, financially sustainable and innovative medicines.
Learn how we evaluate technologies
Health technology evaluation and topic selection manuals
Updated manuals for methods, processes and topic selection.
Digital health technologies
Accelerating our efforts to deliver innovation to the health and care system.
Evidence standards framework
Using the best available evidence to develop recommendations that guide decisions in health, public health and social care.
Our guidance programmes
Ensuring new technologies are clinically effective and offer economic value.
Register your product
Non-pharmaceutical
NHS Innovation Service is a clear and simple point of entry for health technologies to access support and national evaluation programmes.
Pharmaceutical
UK PharmaScan is a database of new medicines, indications and formulations in the pharmaceutical pipeline.
Find published and proposed evaluations
Diagnostics
Guidance on measurements and tests used to evaluate a patient's condition.
Medical technologies
Guidance on medical technologies put forward to NICE by manufacturers.
Technology appraisals
Guidance on new and existing medicines and treatments in the NHS.
Highly specialised technologies
Guidance on the use of highly specialised medicines and treatments.
British National Formulary (BNF)
British National Formulary for Children (BNFC)
Clinical Knowledge Summaries (CKS)
Skip About submenu
About
NICE helps practitioners and commissioners get the best care to patients, fast, while ensuring value for the taxpayer.
Explore about
Our programmes
Learn about the information we produce.
Guidance
Advice
Quality standards
Indicators
Digital health
Topic selection
Get involved
Understand how decisions are made:
Attend a committee meeting
Comment on draft guidance:
Guidance in consultation
Be part of a guidance committee:
Join a committee
Help develop our products:
Register as a stakeholder
Putting you at the heart of our work:
Public involvement
What we do
Social care
Life sciences
NICE international
Patient safety
Shared decision making
Into practice
Social care quick guides
Measuring the use of NICE guidance
Resource planner
View all Into practice
Who we are
The board
The NICE strategy 2021 to 2026
Corporate publications
View all Who we are
- Contact us
- Jobs

History

Guidance published

Equality impact assessment - section 4 (PDF 137 KB)

Published:

19 August 2020
Consultation comments and responses (PDF 1.38 MB)

Published:

19 August 2020
Committee member list - Declarations of Interest (PDF 706 KB)

Published:

19 August 2020
Committee member list (PDF 122 KB)

Published:

19 August 2020

Draft guidance consultation

Draft guidance consultation
Supporting documentation - Methodology (PDF 656 KB)

Published:

06 December 2019
Supporting documentation - Acknowledgements (PDF 140 KB)

Published:

06 December 2019
Addendum appendix - Cost-effectiveness analysis for cardiac output monitoring (PDF 1.47 MB)

Published:

06 December 2019
Committee member list (PDF 576 KB)

Published:

06 December 2019
Committee member list - Registration of interests (PDF 84 KB)

Published:

06 December 2019
Evidence review A - Information and support (PDF 1.38 MB)

Published:

06 December 2019
Evidence review B - Enhanced recovery (PDF 3.73 MB)

Published:

06 December 2019
Evidence review C - Risk tools (PDF 1.54 MB)

Published:

06 December 2019
Evidence review D - Pre-op optimisation (PDF 913 KB)

Published:

06 December 2019
Evidence review E - Management of anaemia (PDF 1.02 MB)

Published:

06 December 2019
Evidence review G - Nutrition (PDF 696 KB)

Published:

06 December 2019
Evidence review H - Fasting (PDF 1.75 MB)

Published:

06 December 2019
Evidence review I - IV fluids (PDF 1.41 MB)

Published:

06 December 2019
Evidence review J - Cardiac monitoring (PDF 1.82 MB)

Published:

06 December 2019
Evidence review K - Glucose (PDF 1.8 MB)

Published:

06 December 2019
Evidence review L - Safety management systems (PDF 1.16 MB)

Published:

06 December 2019
Evidence review M - Specialist recovery areas (PDF 1.09 MB)

Published:

06 December 2019
Evidence review N1 - Management of pain (PDF 3.75 MB)

Published:

06 December 2019
Evidence review N2 - Management of pain appendices (PDF 10.22 MB)

Published:

06 December 2019
Evidence review F - Anticoagulation management (PDF 880 KB)

Published:

06 December 2019
Comments form (MSWord 37 KB)

Published:

06 December 2019
Short version of draft guideline (PDF 414 KB)

Published:

09 December 2019
Equality impact assessment - Section 3 (PDF 112 KB)

Published:

19 August 2020

Pre-consultation documents released

Search strategies (PDF 4.41 MB)

Published:

25 September 2019
Review questions (PDF 95 KB)

Published:

25 September 2019
Economic plan (PDF 104 KB)

Published:

25 September 2019

Declaration of interests

Register of interests (PDF 581 KB)

Published:

01 August 2019

Committee list updated

Committee member list (PDF 195 KB)

Published:

06 September 2018

Stakeholder list updated

Stakeholder list (PDF 43 KB)

Published:

19 September 2019

Committee meetings

Committee meeting
Minutes - GC1 (PDF 235 KB)

Published:

15 March 2018
Minutes - GC2 (PDF 222 KB)

Published:

18 April 2018
Minutes - GC3 (PDF 199 KB)

Published:

07 June 2018
Minutes - GC4 (PDF 226 KB)

Published:

25 July 2018
Minutes - GC5 (PDF 199 KB)

Published:

05 September 2018
Minutes - GC6 (PDF 255 KB)

Published:

25 October 2018
Minutes - GC7 (PDF 155 KB)

Published:

30 January 2019
Minutes - GC8 (PDF 145 KB)

Published:

31 January 2019
Minutes - GC9 (PDF 151 KB)

Published:

13 March 2019
Minutes - GC10 (PDF 181 KB)

Published:

24 April 2019
Minutes - GC11 (PDF 170 KB)

Published:

25 April 2019
Minutes - GC12 (PDF 177 KB)

Published:

30 May 2019
Minutes - GC13 (PDF 178 KB)

Published:

11 July 2019
Minutes - GC14 (PDF 344 KB)

Published:

05 February 2020

Equality and health inequalities assessment

Equality impact assessment 2 (PDF 150 KB)

Published:

27 February 2018

Scope published

Final scope (PDF 294 KB)

Published:

27 February 2018
Consultation comments and responses (PDF 546 KB)

Published:

27 February 2018
Equality impact assessment - Section 2 (PDF 150 KB)

Published:

19 August 2020

Draft scope consultation

Draft scope consultation
Draft scope (PDF 419 KB)

Published:

15 November 2017
Comments form (MSWord 65 KB)

Published:

15 November 2017
Equality impact assessment - Section 1 (PDF 229 KB)

Published:

19 August 2020

Scoping workshop

Workshop notes Group 1 (PDF 363 KB)

Published:

15 November 2017
Workshop notes Group 2 (PDF 353 KB)

Published:

15 November 2017